Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer

2018247 citationsJournal Articlebronze Open Access

Authors

ClinicalTrials.gov Identifier: NCT01812746.

Good health and well-being

Published in: JAMA Oncology

Volume 4, Issue 10, pp. 1344-1344

Field-Weighted Citation Impact: 20.02